Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21573) 21573
Publication (2413) 2413
Newspaper Article (1034) 1034
Newsletter (716) 716
Book Review (401) 401
Book / eBook (306) 306
Book Chapter (275) 275
Magazine Article (169) 169
Web Resource (56) 56
Trade Publication Article (48) 48
Conference Proceeding (44) 44
Reference (25) 25
Dissertation (24) 24
Report (14) 14
Data Set (8) 8
Paper (2) 2
Government Document (1) 1
Streaming Video (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (15238) 15238
index medicus (9442) 9442
animals (6556) 6556
female (6082) 6082
viruses (5403) 5403
hepatitis (5022) 5022
male (4817) 4817
virology (4768) 4768
immunology (4488) 4488
infections (4471) 4471
adult (3988) 3988
vaccines (3956) 3956
infectious diseases (3817) 3817
vaccination (3615) 3615
health aspects (3569) 3569
research (3441) 3441
infection (3393) 3393
viral infections (3193) 3193
research article (3150) 3150
microbiology (2962) 2962
virus diseases (2917) 2917
proteins (2648) 2648
viral vaccines (2645) 2645
medicine (2637) 2637
mice (2619) 2619
middle aged (2506) 2506
hepatitis b - prevention & control (2425) 2425
immunization (2416) 2416
antibodies (2373) 2373
hepatitis b (2351) 2351
multidisciplinary sciences (2130) 2130
adolescent (1971) 1971
science (1899) 1899
child (1852) 1852
antigens (1837) 1837
hepatitis b virus (1772) 1772
biology (1756) 1756
immune response (1665) 1665
risk factors (1608) 1608
analysis (1607) 1607
hepatitis b vaccines (1567) 1567
hiv (1546) 1546
epidemiology (1519) 1519
prevention (1493) 1493
hepatitis c virus (1483) 1483
medical research (1465) 1465
hepatitis b virus - immunology (1457) 1457
infant (1455) 1455
medicine, research & experimental (1426) 1426
hepatitis a (1423) 1423
vaccine (1417) 1417
antibodies, viral - blood (1415) 1415
viral diseases (1320) 1320
genetic aspects (1312) 1312
genomes (1312) 1312
molecular sequence data (1312) 1312
viral hepatitis vaccines - immunology (1268) 1268
human immunodeficiency virus--hiv (1251) 1251
hepatitis c (1241) 1241
immunity (1240) 1240
cell line (1227) 1227
studies (1212) 1212
child, preschool (1204) 1204
immune system (1191) 1191
prevalence (1183) 1183
interferon (1174) 1174
physiological aspects (1164) 1164
public health (1159) 1159
hepatitis b virus - genetics (1154) 1154
aged (1146) 1146
immunogenicity (1136) 1136
viral vaccines - immunology (1136) 1136
mutation (1126) 1126
young adult (1122) 1122
viral antibodies (1120) 1120
replication (1116) 1116
genotype (1098) 1098
gene expression (1086) 1086
gastroenterology & hepatology (1081) 1081
viral hepatitis vaccines - administration & dosage (1073) 1073
digestive system diseases (1052) 1052
virus (1044) 1044
disease (1043) 1043
dna (1043) 1043
amino acid sequence (1038) 1038
hepatitis b - immunology (1028) 1028
mice, inbred balb c (1028) 1028
lymphocytes (1023) 1023
biology and life sciences (1021) 1021
influenza (1019) 1019
viral load (1006) 1006
t cells (990) 990
article (987) 987
deoxyribonucleic acid--dna (982) 982
medicine and health sciences (977) 977
rna (969) 969
children (968) 968
enzyme-linked immunosorbent assay (965) 965
hepatitis b surface antigens - immunology (964) 964
care and treatment (962) 962
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (215) 215
Online Resources - Online (22) 22
Collection Dvlpm't (Acquisitions) - Closed Orders (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (19) 19
UofT at Mississauga - Stacks (12) 12
UofT at Scarborough - Stacks (12) 12
UTL at Downsview - May be requested (11) 11
Earth Sciences (Noranda) - Stacks (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Course Reserves (2) 2
Credit Valley Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Law (Bora Laskin) - Stacks (1) 1
New College (Ivey) - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Scarborough - Withdrawn (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22196) 22196
French (388) 388
German (335) 335
Russian (283) 283
Spanish (222) 222
Chinese (179) 179
Japanese (106) 106
Italian (102) 102
Polish (101) 101
Dutch (57) 57
Portuguese (45) 45
Czech (36) 36
Danish (28) 28
Romanian (28) 28
Swedish (27) 27
Hungarian (18) 18
Bulgarian (12) 12
Croatian (11) 11
Norwegian (11) 11
Turkish (11) 11
Hebrew (10) 10
Korean (10) 10
Finnish (7) 7
Ukrainian (4) 4
Serbian (3) 3
Arabic (2) 2
Azerbaijani (1) 1
Greek (1) 1
Icelandic (1) 1
Lithuanian (1) 1
Persian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Hepatitis and liver cancer
: a national strategy for prevention and control of hepatitis B and C
by Colvin, Heather M and Mitchell, Abigail E and Institute of Medicine (U.S.). Board on Population Health and Public Health Practice and Institute of Medicine (U.S.). Committee on the Prevention and Control of Viral Hepatitis Infections and National Academies Press (U.S.) and Board on Population Health and Public Health Practice and Institute of Medicine and Committee on the Prevention and Control of Viral Hepatitis Infections
2010, ISBN 0309146283, xix, 232
"The global epidemic of hepatitis B and C is a serious public health problem. Hepatitis B and C are the major causes of chronic liver disease and liver cancer... 
Viral Hepatitis Vaccines | complications | Liver | prevention & control | Hepatitis C | Liver Neoplasms | therapeutic use | Hepatitis B | Cancer | United States
Book
Details down arrow
2. Full Text Long-Term Efficacy of a Hepatitis E Vaccine
by Zhang, Xue-Feng and Zhang, Jun and Huang, Shou-Jie and Wu, Ting and Hu, Yue-Mei and Wang, Hua and Wang, Yi-Jun and Wang, Zhong-Ze and Jiang, Ren-Jie and Jiang, Han-Min and Yan, Qiang and Guo, Meng and Liu, Xiao-Hui and Li, Jing-Xin and Li, Yi-Min and Yang, Chang-Lin and Tang, Quan and Pan, Hui-Rong and Shih, J. Wai-Kuo and Ng, Mun-Hon and Zhu, Feng-Cai and Xia, Ning-Shao
The New England Journal of Medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 10, pp. 914 - 922
Hepatitis E virus is a common cause of illness worldwide and is associated with severe complications, especially in pregnant women. In this report, the... 
MEDICINE, GENERAL & INTERNAL | E VIRUS-INFECTION | VIRAL-HEPATITIS | DEVELOPED-COUNTRIES | PREGNANCY | Viral Hepatitis Vaccines - adverse effects | Double-Blind Method | Immunoglobulin G - blood | Humans | Middle Aged | Genotype | Male | Hepatitis E virus - genetics | Young Adult | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Hepatitis E virus - immunology | Time Factors | Hepatitis Antibodies - blood | Adolescent | Hepatitis E - immunology | Adult | Female | Aged | Hepatitis E | Care and treatment | Immunization | Usage | Safety and security measures | Dosage and administration | Risk factors | Hepatitis G virus | Hepatitis | Motivation | Immunogenicity | Antibodies | Vaccines | Hepatitis B
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Hepatitis e vaccine debuts
by Park, Soo Bin
Nature, ISSN 0028-0836, 11/2012, Volume 491, Issue 7422, pp. 21 - 22
More than a decade ago, researchers at Xiamen University in Fujian province genetically modified a strain of the bacterium Escherichia coli to produce a... 
MULTIDISCIPLINARY SCIENCES | Hepatitis E - epidemiology | Pregnancy | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - economics | Africa - epidemiology | Drug Industry - economics | Humans | Biotechnology - economics | Female | China - epidemiology | Vaccines, Synthetic - economics | Public-Private Sector Partnerships | Hepatitis | Renminbi | Vaccines | Mortality
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Hepatitis B vaccines in clinical practice
by Ellis, Ronald W
1993, Infectious disease and therapy, ISBN 0824787803, Volume 7., xiii, 418
Hepatitis B vaccine | Vaccination | Hepatitis B
Book
Details down arrow
5. Full Text Hepatitis vaccines
by Karayiannis, Peter and Main, Janice and Thomas, Howard C
British Medical Bulletin, ISSN 0007-1420, 2004, Volume 70, Issue 1, pp. 29 - 49
DNA-BASED IMMUNIZATION | MEDICINE, GENERAL & INTERNAL | LONG-TERM IMMUNOGENICITY | HEALTH-CARE WORKERS | WOODCHUCKS MARMOTA-MONAX | B-VIRUS-INFECTION | CELLULAR IMMUNE-RESPONSES | FOLLOW-UP | C VIRUS | CYTOTOXIC T-LYMPHOCYTES | A VACCINE | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Hepatitis - prevention & control | Hepatitis D - prevention & control | Viral Hepatitis Vaccines - administration & dosage | Humans | Hepatitis A - prevention & control | Hepatitis B - prevention & control | Vaccines, Synthetic - administration & dosage | Hepatitis C - prevention & control | Vaccines, DNA - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Handbook of hepatitis C
by Goossens, Nicolas and Clément, Sophie (Of Hôpitaux universitaires de Genève) and Negro, Francesco, 1957
2016, ISBN 9783319280530
Viral Hepatitis Vaccines | Hepatitis C | Hepacivirus | therapeutic use
Web Resource
Details down arrow
7. Full Text Safety and Efficacy of a Recombinant Hepatitis E Vaccine
by Shrestha, Sanjaya Kumar and Shrestha, Mrigendra Prasad and Scott, Robert McNair and Joshi, Durga Man and Mammen, Mammen P and Thapa, Gyan Bahadur and Thapa, Narbada and Myint, Khin Saw Aye and Fourneau, Marc and Kuschner, Robert A and David, Marie Pierre and Seriwatana, Jitvimol and Vaughn, David W and Safary, Assad and Endy, Timothy P and Innis, Bruce L
The New England Journal of Medicine, ISSN 0028-4793, 03/2007, Volume 356, Issue 9, pp. 895 - 903
Seroprevalence studies suggest that one third of the world's population has been infected with hepatitis E virus (HEV). Infection, especially during pregnancy,... 
IMMUNOGLOBULIN | MEDICINE, GENERAL & INTERNAL | E VIRUS-INFECTION | PHYLOGENETIC ANALYSIS | DISEASE | NEPAL | Viral Hepatitis Vaccines - adverse effects | Viral Hepatitis Vaccines - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Vaccines, Synthetic - immunology | Incidence | Hepatitis E - epidemiology | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Hepatitis E virus - immunology | Vaccines, Synthetic - adverse effects | Hepatitis Antibodies - blood | Adolescent | Adult | Female | Vaccines, Synthetic - administration & dosage | Hepatitis, Viral | Causes of | Care and treatment | Drug therapy | Hepatitis E virus | Risk factors | Medical research | Genotype & phenotype | Hepatitis | Armed forces | Vaccines
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Design of therapeutic vaccines: hepatitis B as an example
by Kutscher, Sarah and Bauer, Tanja and Dembek, Claudia and Sprinzl, Martin and Protzer, Ulrike
Microbial Biotechnology, ISSN 1751-7915, 03/2012, Volume 5, Issue 2, pp. 270 - 282
Therapeutic vaccines are currently developed for chronic viral infections, such as human papillomavirus (HPV), human immunodeficiency virus (HIV), herpesvirus... 
IMMUNE-RESPONSE | T-CELL RESPONSES | CHRONIC HBV INFECTION | VIRUS-INFECTION | GERMAN GUIDELINE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | COMBINATION THERAPY | TERM-FOLLOW-UP | MICROBIOLOGY | SURFACE-ANTIGEN | LYMPHOCYTE RESPONSE | CORE ANTIGEN | Hepatitis B Vaccines - therapeutic use | Immunotherapy - methods | Hepatitis B, Chronic - immunology | Immunity, Humoral | Humans | Hepatitis B, Chronic - therapy | Immunity, Cellular | Antigens | Immune response | Vaccination | Antibodies | Viruses | Lymphocytes T | Infections | Vaccines | Immune response (humoral) | Hepatitis | Human papillomavirus | Lymphocytes | Human immunodeficiency virus--HIV | Human papilloma viruses | Hepatitis B virus | Viral infections | Hepatitis B | Immune system | Neutralization
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Prophylactic hepatitis E vaccine
by Zhang, Jun and Zhao, Qinjian and Xia, Ningshao
Advances in Experimental Medicine and Biology, ISSN 0065-2598, 10/2016, Volume 948, pp. 223 - 246
Hepatitis E has been increasingly recognized as an underestimated global disease burden in recent years. Subpopulations with more serious infection-associated... 
Efficacy | Vaccine | Epitope | Immunogenicity | Neutralizing antibody | LIVER-TRANSPLANT RECIPIENTS | STRUCTURAL PROTEIN | MEDICINE, RESEARCH & EXPERIMENTAL | CAPSID PROTEIN | INFECTIOUS DISEASES | RHESUS-MONKEYS | RECOMBINANT VACCINE | INSECT CELLS | HEV INFECTION | IMMUNOLOGY | E VIRUS-INFECTION | PROTECTIVE IMMUNITY | VIROLOGY | MONOCLONAL-ANTIBODIES | Humans | Viral Vaccines - genetics | Viral Proteins - immunology | Viral Proteins - genetics | Hepatitis E - virology | Hepatitis E virus - genetics | Viral Vaccines - administration & dosage | Hepatitis E - prevention & control | Antibodies, Neutralizing - immunology | Animals | Hepatitis E virus - immunology | Hepatitis E - immunology | Viral Proteins - administration & dosage | Viral Vaccines - immunology | Hepatitis E virus - isolation & purification
Journal Article
Details down arrow
10. Hepatitis C
: cure of infection
by Mailliard, Mark
2016, Gastroenterology and hepatology : pathophysiology, presentation, diagnosis and management
drug therapy | pathology | Viral Hepatitis Vaccines | Vaccination | drug effects | Antiviral Agents | Prevention | Treatment | genetics | virology | Hepatitis C virus | Hepatitis C | Hepacivirus | therapeutic use | Sofosbuvir
Web Resource
Details down arrow
11. Immunization safety review
: hepatitis B vaccine and demyelinating neurological disorders
by Stratton, Kathleen R and Almario, Donna A and McCormick, Marie C and Institute of Medicine (U.S.). Immunization Safety Review Committee
2002, ISBN 9780309084697, xiii, 106
Immunization | Demyelination | Complications | Hepatitis B Vaccines | Vaccination | adverse effects | Hepatitis B vaccine | Health Policy | Demyelinating Diseases | Hepatitis B | etiology
Book
Details down arrow
12. Full Text A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
by Swadling, Leo and Capone, Stefania and Antrobus, Richard D and Brown, Anthony and Richardson, Rachel and Newell, Evan W and Halliday, John and Kelly, Christabel and Bowen, Dan and Fergusson, Joannah and Kurioka, Ayako and Ammendola, Virginia and Del Sorbo, Mariarosaria and Grazioli, Fabiana and Esposito, Maria Luisa and Siani, Loredana and Traboni, Cinzia and Hill, Adrian and Colloca, Stefano and Davis, Mark and Nicosia, Alfredo and Cortese, Riccardo and Folgori, Antonella and Klenerman, Paul and Barnes, Eleanor
Science Translational Medicine, ISSN 1946-6234, 11/2014, Volume 6, Issue 261, pp. 261ra153 - 261ra153
A protective vaccine against hepatitis C virus (HCV) remains an unmet clinical need. HCV infects millions of people worldwide and is a leading cause of liver... 
MEDICINE, RESEARCH & EXPERIMENTAL | CHALLENGE | NEUTRALIZING ANTIBODIES | HEPATITIS-C VIRUS | SINGLE-SOURCE OUTBREAK | IMMUNE-RESPONSES | PERSISTENCE | STAGE MALARIA | CYTOKINE EXPRESSION | VIRAL CLEARANCE | ACUTE INFECTION | CELL BIOLOGY | Cell Proliferation | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Viral Vaccines - genetics | England | Hepacivirus - genetics | Hepacivirus - pathogenicity | Healthy Volunteers | CD4-Positive T-Lymphocytes - immunology | Hepatitis C - immunology | Vaccination - methods | Time Factors | Hepatitis C Antibodies - blood | Adenoviridae - genetics | Adenoviridae - immunology | CD4-Positive T-Lymphocytes - virology | Hepatitis C - prevention & control | Interferon-gamma Release Tests | Lymphocyte Activation | Cells, Cultured | Histocompatibility Antigens Class I - immunology | Treatment Outcome | Enzyme-Linked Immunospot Assay | Pan troglodytes | Viral Vaccines - administration & dosage | Hepatitis C - diagnosis | Viral Hepatitis Vaccines - immunology | Animals | CD8-Positive T-Lymphocytes - virology | Hepatitis C - virology | Viral Hepatitis Vaccines - genetics | Immunologic Memory | CD8-Positive T-Lymphocytes - immunology | Viral Vaccines - immunology | modified vaccinia Ankara | Hepatitis | Prophylactic | Adenoviral | HCV | Vaccine | Hepatitis C Virus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Hepatitis A vaccines
by Nothdurft, Hans Dieter
Expert Review of Vaccines, ISSN 1476-0584, 07/2008, Volume 7, Issue 5, pp. 535 - 545
The global disease burden associated with hepatitis A virus (HAV) is expected to increase in the coming years due to a shift in the epidemiological pattern of... 
Prevention | Control | Outbreak | Hepatitis A vaccine | Travelers' vaccine | Epidemiology | Hepatitis A | hepatitis A vaccine | travelers' vaccine | RISK-FACTORS | hepatitis A | SAFETY | control | IMMUNOLOGY | epidemiology | DRUG-USERS | IMMUNIZATION | IMMUNOGENICITY | INFANTS | outbreak | BOOSTER VACCINATION | ANTIBODY-RESPONSE | VIRAL-HEPATITIS | prevention | Mass Vaccination | Travel | Hepatitis A - immunology | Vaccination - methods | Hepatitis A - epidemiology | Hepatitis A Vaccines - standards | Humans | Adult | Hepatitis A - prevention & control | Hepatitis A Vaccines - administration & dosage
Journal Article
Details down arrow
14. Full Text Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
by Torresi, Joseph and Johnson, Doug and Wedemeyer, Heiner
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 54, Issue 6, pp. 1273 - 1285
Hepatitis C virus (HCV) is a blood borne disease estimated to chronically infect 3% of the worlds’ population causing significant morbidity and mortality.... 
Gastroenterology and Hepatology | Preventative vaccines | Therapeutic vaccines | Antivirals | Cellular immunity | Vaccines | Hepatitis C | Neutralising antibody | NEUTRALIZING ANTIBODIES | DENDRITIC CELLS | ENVELOPE PROTEIN | I CLINICAL-TRIAL | HCV INFECTION | HYPERVARIABLE REGION 1 | SCAVENGER RECEPTOR-BI | T-CELL RESPONSES | IMMUNE-RESPONSES | GASTROENTEROLOGY & HEPATOLOGY | PHASE-I | Antibodies, Viral - biosynthesis | Hepatitis C - therapy | Hepacivirus - immunology | Humans | Clinical Trials as Topic | Viral Hepatitis Vaccines - therapeutic use | Virus Internalization | Host-Pathogen Interactions - immunology | Epitopes - immunology | Hepatitis C - immunology | Models, Immunological | Animals | Antibodies, Neutralizing - biosynthesis | Viral Hepatitis Vaccines - isolation & purification | Hepatitis C - prevention & control | Immunity, Cellular | Virus diseases | Peptides | Dendritic cells | Cross infection | Nosocomial infections | Biological response modifiers | Hepatitis C virus | T cells | Health aspects | Recombinant proteins | Antigenic determinants
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Prospects for Prophylactic and Therapeutic Vaccines Against Hepatitis C Virus
by Stephen M. Feinstone and Dale J. Hu and Marian E. Major
Clinical Infectious Diseases, ISSN 1058-4838, 7/2012, Volume 55, Issue suppl_1, pp. S25 - S32
Natural cross-protective immunity is induced after spontaneous clearance of primary hepatitis C virus (HCV) infection. Although this suggests that effective... 
T lymphocytes | Animal models | Vaccination | Medical treatment | Antivirals | Clinical trials | Viruses | Infections | Hepatitis C | Hepacivirus | UNITED-STATES | INFECTIOUS DISEASES | NEUTRALIZING ANTIBODIES | MICROBIOLOGY | IMMUNOLOGY | INJECTION-DRUG USERS | T-CELL RESPONSES | ENVELOPE GLYCOPROTEINS | IMMUNE-RESPONSES | INFECTION | HCV | HEALTHY-VOLUNTEERS | PHASE-I | Liver - virology | Hepatitis C - therapy | Liver - pathology | Hepacivirus - immunology | Viral Hepatitis Vaccines - administration & dosage | Humans | Hepacivirus - genetics | Hepacivirus - pathogenicity | RNA, Viral - blood | Clinical Trials as Topic | Viral Load - immunology | Viral Hepatitis Vaccines - therapeutic use | Genetic Variation | Hepatitis C - immunology | Viral Hepatitis Vaccines - immunology | Animals | Virus Replication | Risk-Taking | Hepatitis C - virology | Hepacivirus - physiology | RNA, Viral - immunology | Immunity, Cellular
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial
by Zhu, Feng-Cai, MSc and Zhang, Jun, Prof and Zhang, Xue-Feng, MSc and Zhou, Cheng, MD and Wang, Zhong-Ze, MD and Huang, Shou-Jie, MD and Wang, Hua, MD and Yang, Chang-Lin, BSc and Jiang, Han-Min, BSc and Cai, Jia-Ping, BSc and Wang, Yi-Jun, BSc and Ai, Xing, MSc and Hu, Yue-Mei, MD and Tang, Quan, MD and Yao, Xin, MSc and Yan, Qiang, MSc and Xian, Yang-Ling, BSc and Wu, Ting, Prof and Li, Yi-Min, MD and Miao, Ji, Prof and Ng, Mun-Hon, Prof and Shih, James Wai-Kuo, Prof and Xia, Ning-Shao, Prof, Dr
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9744, pp. 895 - 902
Summary Background Seroprevalence data suggest that a third of the world's population has been infected with the hepatitis E virus. Our aim was to assess... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CHRONIC LIVER-DISEASE | ZOONOSIS | IGG | E VIRUS-INFECTION | VIRAL-HEPATITIS | PREGNANCY | Hepatitis E virus - drug effects | Double-Blind Method | Immunoglobulin G - blood | Viral Hepatitis Vaccines - administration & dosage | Humans | Middle Aged | Male | Treatment Outcome | Vaccines, Synthetic - immunology | Young Adult | Hepatitis E - prevention & control | Viral Hepatitis Vaccines - immunology | Hepatitis E virus - immunology |